Rep. Tom Price (R-GA) “got a privileged offer to buy a biomedical stock at a discount, the company’s officials said, contrary to his congressional testimony this month,” the Wall Street Journal reports.
“The shares were discounted 12% off the traded price in mid-June only for investors who participated in a private placement arranged to raise money to complete a clinical trial. The company’s shares have tripled since the offering.”
Save to Favorites